Appili Therapeutics Inc. (TSX:APLI)
Canada
· Delayed Price · Currency is CAD 0.0250
-0.0050 (-16.67%)
Apr 24, 2025, 9:53 AM EDT
Appili Therapeutics Balance Sheet
Financials in millions CAD. Fiscal year is April - March.
Millions CAD. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2017 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | Mar '20 Mar 31, 2020 | 2017 - 2019 |
| Cash & Equivalents | 0.19 | 0.09 | 2.47 | 6.66 | 11.06 | 10.51 | Upgrade
|
| Short-Term Investments | - | - | - | - | 5.06 | 0.03 | Upgrade
|
| Cash & Short-Term Investments | 0.19 | 0.09 | 2.47 | 6.66 | 16.12 | 10.54 | Upgrade
|
| Cash Growth | -69.12% | -96.17% | -63.00% | -58.67% | 52.98% | 93.34% | Upgrade
|
| Other Receivables | 1.76 | 1.17 | 0.42 | 1.39 | 1.69 | 0.31 | Upgrade
|
| Receivables | 1.76 | 1.17 | 0.42 | 1.39 | 1.69 | 0.31 | Upgrade
|
| Inventory | - | - | - | - | - | 0.04 | Upgrade
|
| Prepaid Expenses | 0.13 | 0.19 | 0.23 | 0.18 | 0.45 | 0.22 | Upgrade
|
| Total Current Assets | 2.07 | 1.46 | 3.12 | 8.24 | 18.26 | 11.11 | Upgrade
|
| Property, Plant & Equipment | 0.02 | 0.03 | 0.01 | 0.04 | 0.05 | 0.06 | Upgrade
|
| Total Assets | 2.09 | 1.49 | 3.13 | 8.28 | 18.32 | 11.17 | Upgrade
|
| Accounts Payable | 4.4 | 4.11 | 2.75 | 6.38 | 4.45 | 1.26 | Upgrade
|
| Accrued Expenses | 0.04 | 0.08 | 0.08 | 0.07 | 0.08 | 0.06 | Upgrade
|
| Current Portion of Long-Term Debt | 10.47 | 7.31 | 0.11 | 0.1 | 0.09 | 0.05 | Upgrade
|
| Current Income Taxes Payable | 0 | 0.05 | 0.04 | - | - | - | Upgrade
|
| Total Current Liabilities | 14.91 | 11.54 | 2.98 | 6.67 | 4.62 | 1.38 | Upgrade
|
| Long-Term Debt | 0.81 | 0.88 | 7.55 | 4.88 | 0.95 | 0.95 | Upgrade
|
| Total Liabilities | 15.72 | 12.42 | 10.53 | 11.55 | 5.56 | 2.33 | Upgrade
|
| Common Stock | 42.32 | 42.32 | 42.32 | 39.65 | 34.96 | 20.99 | Upgrade
|
| Additional Paid-In Capital | 14.82 | 12.87 | 6.41 | 5.01 | 2.55 | 1.81 | Upgrade
|
| Retained Earnings | -71.95 | -69.09 | -65.31 | -56.07 | -30.95 | -16.63 | Upgrade
|
| Comprehensive Income & Other | 1.18 | 2.98 | 9.18 | 8.13 | 6.19 | 2.67 | Upgrade
|
| Shareholders' Equity | -13.63 | -10.92 | -7.4 | -3.27 | 12.75 | 8.85 | Upgrade
|
| Total Liabilities & Equity | 2.09 | 1.49 | 3.13 | 8.28 | 18.32 | 11.17 | Upgrade
|
| Total Debt | 11.28 | 8.18 | 7.67 | 4.98 | 1.03 | 1.01 | Upgrade
|
| Net Cash (Debt) | -11.1 | -8.09 | -5.2 | 1.69 | 15.09 | 9.54 | Upgrade
|
| Net Cash Growth | - | - | - | -88.83% | 58.28% | 120.06% | Upgrade
|
| Net Cash Per Share | -0.09 | -0.07 | -0.05 | 0.03 | 0.26 | 0.28 | Upgrade
|
| Filing Date Shares Outstanding | 121.27 | 121.27 | 121.27 | 121.27 | 62.83 | 61.6 | Upgrade
|
| Total Common Shares Outstanding | 121.27 | 121.27 | 121.27 | 71.27 | 62.78 | 46.4 | Upgrade
|
| Working Capital | -12.84 | -10.08 | 0.14 | 1.57 | 13.65 | 9.73 | Upgrade
|
| Book Value Per Share | -0.11 | -0.09 | -0.06 | -0.05 | 0.20 | 0.19 | Upgrade
|
| Tangible Book Value | -13.63 | -10.92 | -7.4 | -3.27 | 12.75 | 8.85 | Upgrade
|
| Tangible Book Value Per Share | -0.11 | -0.09 | -0.06 | -0.05 | 0.20 | 0.19 | Upgrade
|
| Machinery | - | 0.08 | 0.06 | 0.13 | 0.14 | 0.13 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.